Quick Answer
Evolus, Inc. reported Research And Development Expense of $2.06 million for the year ending 2021.
- Evolus, Inc. showed an increase of +19.9% in Research And Development Expense from 2020 to 2021.
- This data is from Evolus, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2022.
- XBRL data for this metric is available from 2017 to 2021 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $2.65 million | Q2 2017: $1.37 million | Q3 2017: $1.47 million | Q1 2018: $1.68 million | Q2 2018: $1.65 million | Q3 2018: $1.98 million | Q1 2019: $2.35 million | Q2 2019: $509.0 thousand | Q3 2019: $693.0 thousand | Q1 2020: $507.0 thousand | Q2 2020: $145.0 thousand | Q3 2020: $350.0 thousand | Q1 2021: $841.0 thousand | Q2 2021: $499.0 thousand | Q3 2021: $301.0 thousand | Q1 2022: $468.0 thousand.
- Over the full 5 years of available data (2017 to 2021), Evolus, Inc.'s Research And Development Expense has declined by 69.1%.
- Historical annual values: Fiscal year 2021: $2.06 million | Fiscal year 2020: $1.72 million | Fiscal year 2019: $3.97 million | Fiscal year 2018: $6.49 million | Fiscal year 2017: $6.69 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: